Company / Book Value per Share
NEKTAR THERAPEUTICS Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$7.253
FY2025
5-year range
$0.684 / $7.253
FY2021-FY2025
Trend
+959.8%
vs FY2024
Sector context
#81 of 209
Health Care
What the data says
Book Value per Share changed +960% YoY in FY2025, a notable deviation from the 9-year average annual change of +301%.
Based on SEC 10-K filings.
$7.253 in FY2025 with a 5-year CAGR of -5.7%.
Improved from $1.944 to $7.253 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +54.2%
- 5-Year CAGR
- -5.7%
- 10-Year CAGR
- -
Sector benchmark
#81 of 209 in Health CareTop 39% of 209This company $7.253 Sector average $215.686
▼
-96.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -5.7%, indicating a declining trend.
- In FY2025, book value per share increased 959.8% year-over-year.
- Ranks #81 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.253 | +959.8% |
| FY2024 | $0.684 | -64.8% |
| FY2023 | $1.944 | -1.6% |
| FY2022 | $1.977 | -47.6% |
| FY2021 | $3.773 | -61.2% |
| FY2020 | $9.731 | +1822.7% |
| FY2019 | $0.506 | -8.4% |
| FY2018 | $0.552 | -3.6% |
| FY2017 | $0.573 | +113.5% |
| FY2016 | $0.269 | +448.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026